Brachytherapy
Volume 7, Issue 1 , Pages 17-21 , January 2008

Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy

  • Hoon K. Lee

      Affiliations

    • Richmond University Medical Center, 355 Bard Avenue, Staten Island, NY 10310
    • Department of Radiation Oncology, Regional Imaging & Therapeutic Radiology Services, 360 Bard Avenue, Staten Island, NY 10310
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Regional Imaging & Therapeutic Radiology Services, 360 Bard Avenue, Staten Island, NY 10310. Tel.: +1-718-876-2023; fax: +1-718-876-4524.
    • ,
  • Marc T. Adams

      Affiliations

    • Richmond University Medical Center, 355 Bard Avenue, Staten Island, NY 10310
    • Department of Radiation Oncology, Regional Imaging & Therapeutic Radiology Services, 360 Bard Avenue, Staten Island, NY 10310
    • ,
  • Joseph Motta

      Affiliations

    • Department of Urology, Richmond University Medical Center, 355 Bard Avenue, Staten Island, NY 10310

Received 14 August 2007 ,Revised 21 November 2007 ,Accepted 21 November 2007.

References 

  1. Kupelian P, Kuban D, Thames H, et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys. 2005;61:415–419
  2. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097–1105
  3. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002;53:1111–1116
  4. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA. 2005;294:1233–1239
  5. Bianco FJ, Scardino PT, Stephenson AJ, et al. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:448–453
  6. Stephenson AJ, Scardino PT, Bianco FJ, et al. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol. 2004;172:2239–2243
  7. Stephenson AJ, Eastham JA. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol. 2005;23:8198–8203
  8. Pisters LL, von Eschenbach AC, Scott SM, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997;157:921–925
  9. Izawa JI, Madsen LT, Scott SM, et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: Variables affecting patient outcome. J Clin Oncol. 2002;20:2664–2671
  10. Perrotte P, Litwin MS, McGuire EJ, et al. Quality of life after salvage cryotherapy: The impact of treatment parameters. J Urol. 1999;162:398–402
  11. Spiess PE, Lee AK, Leibovici D, et al. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer. 2006;107:275–280
  12. Merrick GS, Wallner KE, Butler WM. Prostate cryotherapy: More questions than answers. Urology. 2005;66:9–15
  13. Han KR, Belldegrun AS. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int. 2004;93:14–18
  14. Pisters LL, Perrotte P, Scott SM, et al. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol. 1999;17:2514–2520
  15. Beyer DC. Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology. 1999;54:880–883
  16. Zelefsky MJ, Yamada Y, Cohen G, et al. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: Improved dose distributions with an intraoperative computer-optimized conformal planning technique. Int J Radiat Oncol Biol Phys. 2000;48:601–608
  17. Zelefsky MJ, Yamada Y, Marion C, et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2003;55:956–963
  18. Grado GL, Collins JM, Kriegshauser JS, et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology. 1999;53:2–10
  19. Zagars GK, Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol. 1997;44:213–221
  20. D'Amico AV, Moul J, Carroll PR, et al. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol. 2004;172:S42–S46discussion S46–S47
  21. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491–2499

 Presented in part at the 2006 Prostate Cancer Symposium, San Francisco, CA, February 24–26, 2006.

PII: S1538-4721(07)00279-6

doi: 10.1016/j.brachy.2007.11.002

Brachytherapy
Volume 7, Issue 1 , Pages 17-21 , January 2008

Article Tools

* Image Usage & Resolution